ProSavin: Clinical Trials

2 trials of ProSavin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Terminated 1
Phase 22Completed 1, Terminated 1

Follow ProSavin: new trials by email Literature Review of ProSavin trials Research Report on ProSavin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Long Term Safety and Efficacy Study of ProSavin in Parkinson's Disease
ProSavin - Parkinson's Disease
Phase 1 / Phase 2TerminatedAxovant Sciences Ltd.152011-05-012022-05-03
Phase I/II Study of the Safety, Efficacy and Dose Evaluation of ProSavin for the Treatment of Bilateral Idiopathic Parkinson's Disease
ProSavin - Parkinson's Disease
Phase 1 / Phase 2CompletedOxford BioMedica152008-01-012013-05-13

Conditions studied

Parkinson Disease (2)

Sponsors

Axovant Sciences Ltd. (1)  ·  Oxford BioMedica (1)

Countries

France (2)  ·  United Kingdom (2)

Top investigators

Stephane Palfi, Professor (2)  ·  Roger Barker, Dr (1)

Results publications

PMID 24412048

NIH funding

2009 (1)